by According to Vision Research Report, the global MHealth Apps market size was USD 37.2 billion in 2020 and is expected to reach USD 100.9 billion by 2030 and register a revenue CAGR of 11.7% during the forecast period, 2022-2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39134
Growth Factors
Growing adoption of fitness and medical apps to collect and track individuals’ health-related data and to improve the overall health of the patients’ using smartphones are the major factors anticipated to drive the market. In addition, increasing internet and smartphone penetration and growing awareness in maintaining physical health and lifestyle improvement are also further increasing the adoption, thereby supporting market growth.
Increasing penetration of smartphones and the internet all over the globe in the last couple of years is an important factor accelerating the growth of this market. Furthermore, growing awareness on lifestyle improvement and maintaining personal health and wellness is also one of the factors expected to drive the market in the upcoming years. The rapid increase in remote healthcare
services is also expected to propel the adoption of mobile health applications. Moreover, the growing adoption of mHealth applications by physicians to facilitate better patient engagement and treatment outcomes is also anticipated to increase its adoption.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 100.9 billion by 2030 |
| Growth Rate | CAGR of 11.7% From 2022 to 2030 |
| Largest Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product Type |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Teladoc Health, Inc.; Abbott Laboratories; Johnson and Johnson; AstraZeneca PLC; F. Hoffmann-La Roche Ltd.; Novartis AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer, Inc.; Sanofi; Samsung Electronics Co. Ltd.; Qualcomm Technologies, Inc.; Orange; Google (Alphabet), Inc.; Allscripts; Airstrip Technologies, Inc.; AT&T; Apple, Inc. |
By Type Analysis
The medical apps segment dominated the market for mHealth in 2021 and accounted for the largest revenue share of 97.1%. Increasing awareness to adopt medical applications among the patients and healthcare professionals for better communication and healthcare outcomes is helping in boosting the segment share.
The development of mobile medical applications to monitor patient health and to provide support to physicians for decision-making are other factors that are anticipated to boost segment growth in terms of revenue over the years. The fitness apps segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of fitness-related applications coupled with increasing awareness regarding self-health management.
By Regional Analysis
North America dominated the market for mHealth and accounted for the largest revenue share of 38.2% in 2021. Several factors like increasing awareness among the individuals to adopt mobile health applications, developments in coverage networks, rapid growth in the usage of smartphones, rise in geriatric population, and increasing prevalence of chronic diseases are driving the growth of the mHealth apps market in this region.
The Asia Pacific region is anticipated to exhibit lucrative growth over the forecast years. Fast-growing smartphone penetration and increasing internet users are also expected to drive the market for mHealth over the forecast period in this region.
Key Players
- Teladoc Health, Inc.
- AstraZeneca PLC
- Abbott Laboratories
- Sanofi
- Johnson and Johnson
- Bristol-Myers Squibb Company
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Merck and Co., Inc.
- Pfizer, Inc.
- GlaxoSmithKline plc
- Samsung Electronics Co. Ltd
- Orange
- Qualcomm Technologies, Inc.
- Google (Alphabet), Inc.
- Airstrip Technologies, Inc.
- Apple, Inc.
- AT&T
- Allscripts
Market Segmentation
- By Product Type
- Medical Apps
- Women’s Health Apps
- Personal Health Record Apps
- Medication Management Apps
- Diagnostic Apps
- Remote Monitoring Apps
- Disease Management Apps
- Others
- Fitness Apps
- Diet & Nutrition
- Exercise & Fitness
- Lifestyle & Stress
- Medical Apps
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Asia Pacific
- Australia
- China
- Japan
- South Korea
- India
- Singapore
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global MHealth Apps Market, By Product Type
7.1. MHealth Apps Market, by Product Type, 2021-2030
7.1.1. Medical Apps
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Fitness Apps
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global MHealth Apps Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Product Type (2019-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Product Type (2019-2030)
Chapter 9. Company Profiles
9.1. Teladoc Health, Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. AstraZeneca PLC
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Abbott Laboratories
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Sanofi
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Johnson and Johnson
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Novartis AG
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. F. Hoffmann-La Roche Ltd.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39134
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
